Life360 (LIF) Director Chris Hulls Exercises Options, Sells Shares

What Happened
Chris Hulls, a director of Life360 (LIF), exercised derivative awards to acquire 27,000 shares and then sold 14,345 shares in the open market on July 16, 2026. The exercise was at a weighted average price of $2.53 per share (total cash cost $68,310). The open‑market sale was at a weighted average price of $55.74 per share (total proceeds ≈ $799,590; individual trade prices ranged $55.46–$56.13). The filing also reports a derivative disposition of 27,000 shares at $0.00 related to the exercise. The sale was executed under a pre‑established Rule 10b5‑1 trading plan.

Key Details

• Transaction date: July 16, 2026. Form 4 filed July 20, 2026 (filed on the second business day after the trades).
• Exercise: 27,000 shares @ $2.53 (total $68,310). Derivative disposition: 27,000 @ $0.00 (related to exercise).
• Sale: 14,345 shares @ weighted avg $55.74 (proceeds ≈ $799,590); price range $55.46–$56.13.
• Shares owned after transaction: not specified in the provided excerpt of the filing—see official Form 4 for total holdings.
• Notable footnotes: F1 = sale executed under a Rule 10b5‑1 plan adopted Dec 16, 2025; F4 = weighted average and price range disclosure for the sale; F6 = the option was fully vested and exercisable.

Context

• This was an exercise of derivatives (options) followed by a sale of some shares; the zero‑price derivative disposal reflects the cancellation/conversion of the derivative upon exercise.
• The sale was made under a pre‑established 10b5‑1 plan, which typically indicates the trades were automated under predetermined criteria and not based on contemporaneous inside information.
• Sales by insiders are common and often routine; purchases tend to be more directly interpreted as a bullish signal.